Here are five highlights:
1. The two companies partnered in 2012 to co-develop musculoskeletal healthcare diagnostics.
2. Under the initial partnership, Zimmer Biomet marketed the Synovasure Periprosthetic Joint Infection test.
3. CD Diagnostics creates diagnostics assays that help physicians make decisions which optimize patient care.
4. CD Diagnostics’ laboratories have evaluated more than 40,000 samples.
5. The companies did not disclose financial details of the transaction.
“Our acquisition of CD Diagnostics cements our leadership and competitive advantage in musculoskeletal diagnostics, strengthens our Signature Solutions offering and advances our mission to provide comprehensive musculoskeletal healthcare,” said Dan Williamson, group president of joint reconstruction, Zimmer Biomet.
More articles on devices:
Orthopaedic Implant Company launches nail system for femoral midshaft and distal fractures: 5 things to know
Amedica, Mazor Robotics, InVivo Therapeutics & more: 18 key notes
Global medical electronics market to hit $60B by 2023 — 6 observations
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
